Have you or your loved ones been diagnosed with asthma in children?

You may be eligible to participate in a asthma in children clinical trial.

Have you or your loved ones been diagnosed with asthma in children? You may be eligible to participate in a asthma in children clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Asthma in Children Clinical Trial in Rochester NY
NCT03390556 | Interventional

Have you or your loved ones been diagnosed with asthma in children?

You may be eligible to participate in a asthma in children clinical trial.

Have you or your loved ones been diagnosed with asthma in children? You may be eligible to participate in a asthma in children clinical trial.

Completed

Male & Female

7 - 14

Years old

This study has recruited 44 Participants

The goal of this study is to evaluate a pilot of clinic-based intervention of asthma education. After a scheduled outpatient encounter for well-child care or asthma care has concluded, a pediatric nurse will teach participants (children and their caregivers) about asthma, provide clearly written information about how to manage asthma, and discuss how to manage asthma at home with cooperation between caregivers and children. Families will also receive current asthma prescriptions in clinic, and colored labels will be attached to medications in order to match the color scheme of asthma action plans (green labels for controller medications, red labels for rescue medications). Families will be followed for 3 months after the first clinic visit, including a follow-up visit in clinic 1 month later and a follow-up telephone call 3 months after starting. The nurse will reinforce key educational points and review medication use at the follow-up clinic visit. Families will also be invited to complete an additional in-depth interview following the 1 month clinic follow-up. The investigator hypothesizes that knowledge, self-efficacy, and reported adherence with asthma medications will increase for both caregivers and children/adolescents following the intervention and labeling of delivered medications. In addition, the investigator hypothesizes that children/adolescents will have more symptom free days and improved control following the intervention.